Package 42806-424-05

{"route": ["ORAL"], "spl_id": "4bde570a-dab5-a156-e063-6394a90a4287", "openfda": {"upc": ["0342806426050", "0342806426012", "0342806425053", "0342806425015", "0342806424056", "0342806424605", "0342806426609", "0342806424018"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["f8ad76a2-9f75-4660-973d-34402f314e9c"], "manufacturer_name": ["Epic Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-424-01)", "package_ndc": "42806-424-01", "marketing_start_date": "20230918"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-424-05)", "package_ndc": "42806-424-05", "marketing_start_date": "20230918"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (42806-424-60)", "package_ndc": "42806-424-60", "marketing_start_date": "20230918"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "42806-424_4bde570a-dab5-a156-e063-6394a90a4287", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "42806-424", "generic_name": "bupropion hydrochloride", "labeler_name": "Epic Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA211347", "marketing_category": "ANDA", "marketing_start_date": "20230918", "listing_expiration_date": "20271231"}